Glazer Capital’s Aimei Health Technology Right AFJKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-38,931
Closed -$9K – 305
2025
Q2
$9K Hold
38,931
– – ﹤0.01% 230
2025
Q1
$11K Sell
38,931
-10,737
-22% -$2.75K ﹤0.01% 170
2024
Q4
$6K Sell
49,668
-332
-0.7% -$72 ﹤0.01% 136
2024
Q3
$12K Sell
50,000
-25,000
-33% -$6.15K ﹤0.01% 127
2024
Q2
$16K Sell
75,000
-54,067
-42% -$12.1K ﹤0.01% 126
2024
Q1
$25K Buy
+129,067
New +$25.5K ﹤0.01% 118

Other funds holding AFJKR

Glazer Capital's AFJKR Position: Q3 2025 in Review

Glazer Capital sold out of Aimei Health Technology Right (AFJKR) in Q3 2025, closing a stake of 38,931 shares — an estimated $9K sold.

Glazer Capital first reported a position in AFJKR in Q1 2024 and held it in 6 quarters. The position peaked at $25K in Q1 2024. 12 funds tracked by Wall St. Rank hold AFJKR as of Q3 2025.

  • Glazer Capital reported no remaining Aimei Health Technology Right position as of Q3 2025 after selling out during the quarter.
  • Glazer Capital sold 38,931 Aimei Health Technology Right shares in Q3 2025, an estimated $9K.
  • Glazer Capital first reported a position in Aimei Health Technology Right in Q1 2024 and held it in 6 quarters.
  • Glazer Capital's Aimei Health Technology Right position peaked at $25K in Q1 2024.
  • 12 funds tracked by Wall St. Rank held Aimei Health Technology Right as of Q3 2025.

Based on Glazer Capital's 13F filing for Q3 2025, filed 13 Nov 2025.